您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2022, Vol. 60 ›› Issue (9): 31-34.doi: 10.6040/j.issn.1671-7554.0.2022.0843

• 生育力保护专题 • 上一篇    下一篇

子宫内膜异位症的生育力保护

颜磊,岳彩欣,刘懿淳   

  1. 山东大学生殖医学研究中心 山东大学附属生殖医院, 山东 济南 250012
  • 发布日期:2022-09-02
  • 通讯作者: 颜磊. E-mail:yanlei@sdu.edu.cn
  • 基金资助:
    国家自然科学基金(82071617);山东省重点研发计划(2020ZLYS02)

Fertility preservation in patients with endometriosis

YAN Lei, YUE Caixin, LIU Yichun   

  1. Center for Reproductive Medicine, Shandong University &
    Reproductive Hospital Affiliated to Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-02

摘要: 子宫内膜异位症可通过降低卵巢储备、改变免疫系统和盆腔解剖结构、降低内膜容受性等多种机制影响女性生育力,需要酌情进行生育力的保护和保存。注重早期诊断、规范化治疗和长期管理有助于保护生育力。对某些内膜异位症患者可采取生育力保存措施,包括胚胎冷冻技术、成熟卵母细胞冷冻及卵巢组织冷冻等。子宫内膜异位症的生育力保护需要多学科会诊机制。

关键词: 子宫内膜异位症, 卵巢储备, 生育力保护, 辅助生殖技术

Abstract: Endometriosis can affect female fertility by reducing ovarian reserve, changing the immune system and pelvic anatomical structure, and reducing endometrial receptivity. Therefore, fertility should be protected and preserved in patients with endometriosis. For such patients, early diagnosis, standardized treatment and long-term management can help to protect fertility. In addition, measures such as embryo freezing, mature oocyte freezing and ovarian tissue freezing, can help to preserve fertility. Fertility protection requires a multidisciplinary consultation mechanism.

Key words: Endometriosis, Ovarian reserve, Fertility preservation, Assisted reproductive technology

中图分类号: 

  • R711.6
[1] Agarwal SK, Chapron C, Giudice LC, et al. Clinical diagnosis of endometriosis: a call to action[J]. Am J Obstet Gynecol, 2019, 220(4): 354.e1-.e12.
[2] Becker CM, Bokor A, Heikinheimo O, et al. ESHRE guideline: endometriosis[J]. Hum Reprod Open, 2022, 2022(2): hoac009. doi: 10.1093/hropen/hoac009.
[3] Practice Committee of the American Society for Reproductive Medicine. Endometriosis and infertility: a committee opinion[J]. Fertil Steril, 2012, 98(3): 591-598.
[4] 章婷婷, 方小玲. 子宫内膜异位症生育力保护策略[J]. 中国实用妇科与产科杂志, 2021, 37(3): 281-285.
[5] 李薇薇, 郭艺红. 子宫内膜异位症患者生育力保护[J]. 生殖医学杂志, 2018, 27(6): 595-600.
[6] Smolarz B, Szyo K, Romanowicz H. Endometriosis: epidemiology, classification, pathogenesis, treatment and genetics(review of literature)[J]. Int J Mol Sci, 2021, 22(19): 10554.doi: 10.3390/ijms221910554.
[7] Gordts S, Campo R. Modern approaches to surgical management of endometrioma[J]. Best Pract Res Clin Obstet Gynaecol, 2019, 59: 48-55. doi: 10.1016/j.bpobgyn.2018.12.013.
[8] Carrillo L, Seidman DS, Cittadini E, et al. The role of fertility preservation in patients with endometriosis[J]. J Assist Reprod Genet, 2016, 33(3): 317-323.
[9] Sanchez AM, Vanni VS, Bartiromo L, et al. Is the oocyte quality affected by endometriosis? a review of the literature[J]. J Ovarian Res, 2017, 10(1): 43.
[10] Dongye H, Ji X, Ma X, et al. The impact of endometriosis on embryo quality in in-vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis[J]. Front Med, 2021, 8: 669342. doi: 10.3389/fmed.2021.669342.
[11] Taylor HS, Kotlyar AM, Flores VA. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations[J]. Lancet(London, England), 2021, 397(10276): 839-852.
[12] Lessey BA, Kim JJ. Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why[J]. Fertil Steril, 2017, 108(1): 19-27.
[13] Wang L, Zhang J, Zhang H, et al. Low-dose aspirin can downregulate progesterone resistance and increase the expression of LIF in endometriosis during the implantation window[J]. Gynecolo Endocrinol, 2021, 37(8): 725-729.
[14] Kho RM, Andres MP, Borrelli GM, et al. Surgical treatment of different types of endometriosis: comparison of major society guidelines and preferred clinical algorithms[J]. Best Pract Res Clin Obstet Gynaecol, 2018, 51: 102-110. doi: 10.1016/j.bpobgyn.2018.01.020.
[15] Garcia-Fernandez J, García-Velasco JA. Endometriosis and reproduction: what we have learned[J]. Yale J Biol Med, 2020, 93(4): 571-577.
[16] Nezhat C, Vang N, Tanaka PP, et al. Optimal management of endometriosis and pain[J]. Obstet Gynecol, 2019, 134(4): 834-839.
[17] Hart R, Hickey M, Maouris P, et al. Excisional surgery versus ablative surgery for ovarian endometriomata: a Cochrane Review[J]. Hum Reprod, 2005, 20(11): 3000-3007.
[18] Cohen A, Almog B, Tulandi T. Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis[J]. Fertil Steril, 2017, 108(1): 117-124.
[19] Llarena NC, Falcone T, Flyckt RL. Fertility Preservation in Women with Endometriosis[J]. Clin Med Insights Reprod Health, 2019, 13: 1179558119873386. doi: 10.1177/1179558119873386.
[20] Fisch B, Abir R. Female fertility preservation: past, present and future[J]. Reproduction(Cambridge, England), 2018, 156(1): 11-27.
[21] Elizur SE, Chian RC, Holzer HE, et al. Cryopreservation of oocytes in a young woman with severe and symptomatic endometriosis: a new indication for fertility preservation[J]. Fertil Steril, 2009, 91(1): 293.e1-3.
[22] Raad J, Sonigo C, Tran C, et al. Oocyte vitrification for preserving fertility in patients with endometriosis: first observational cohort study… and many unresolved questions. Letter to the Editor[J]. Eur J Obstet Gynecol Reprod Biol, 2018, 220: 140-141. doi: 10.1016/j.ejogrb.2017.12.001.
[23] 中国妇幼保健协会生育力保存专业委员会. 女性生育力保存临床实践中国专家共识[J].中华生殖与避孕杂志, 2021, 41(5): 383-391.
[24] Donnez J, Squifflet J, Dolmans MM, et al. Orthotopic transplantation of fresh ovarian cortex: a report of two cases[J]. Fertil Steril, 2005, 84(4): 1018.
[25] Pacheco F, Oktay K. Current success and efficiency of autologous ovarian transplantation: a meta-analysis[J]. Reprod Sci, 2017, 24(8): 1111-1120.
[26] Oktay KH, Marin L, Petrikovsky B, et al. Delaying reproductive aging by ovarian tissue cryopreservation and transplantation: is it prime time?[J]. Trends Mol Med, 2021, 27(8): 753-761.
[27] Brezina PR, Kutteh WH, Bailey AP, et al. Fertility preservation in the age of assisted reproductive technologies[J]. Obstet Gynecol Clin North Am, 2015, 42(1): 39-54.
[28] Calagna G, Della Corte L, Giampaolino P, et al. Endometriosis and strategies of fertility preservation: a systematic review of the literature[J]. Eur J obstet Gynecol Reprod Biol, 2020, 254: 218-225. doi: 10.1016/j.ejogrb.2020.09.045.
[1] 万文静,高姗姗. 低分子肝素在生殖领域的应用[J]. 山东大学学报 (医学版), 2025, 63(6): 117-124.
[2] 张舒淇,江延姣,印丹. 生殖道微生物与子宫内膜异位症发展之间的联系[J]. 山东大学学报 (医学版), 2025, 63(5): 120-126.
[3] 徐萍,张信美. 子宫内膜异位症疼痛的机制[J]. 山东大学学报 (医学版), 2025, 63(10): 1-7.
[4] 黄艳,周应芳,彭超. 青少年子宫内膜异位症的管理要点和策略[J]. 山东大学学报 (医学版), 2025, 63(10): 8-12.
[5] 薛铭,梁静,凌斌. 各种类型子宫内膜异位症疼痛特点及治疗研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 13-19.
[6] 赵书睿,赵烨. 围绝经期及绝经后期子宫内膜异位症的诊疗现状[J]. 山东大学学报 (医学版), 2025, 63(10): 20-26.
[7] 梁炎春,严莹,麦华希,姚书忠. 地诺孕素在子宫内膜异位症相关性疼痛中的治疗作用:从基础到临床[J]. 山东大学学报 (医学版), 2025, 63(10): 27-33.
[8] 董向毅,刘昕,刘欣欣,徐亚瑄,赵琳丽,陶国伟. 盆腔深部子宫内膜异位症的超声评价[J]. 山东大学学报 (医学版), 2025, 63(10): 34-42.
[9] 刘振花,连雅囡,米国琳. 子宫内膜异位症疼痛的心理因素及干预措施的研究进展[J]. 山东大学学报 (医学版), 2025, 63(10): 43-51.
[10] 杜煜晗,孙莹,杜惠兰. 红花如意丸对寒凝血瘀型子宫内膜异位症痛经患者疼痛的疗效及机制[J]. 山东大学学报 (医学版), 2025, 63(10): 52-60.
[11] 吴磊丽,蔡华丽,孙德胜,魏蔚霞. 超声引导穿刺硬化术联合地诺孕素治疗卵巢子宫内膜异位囊肿的疗效[J]. 山东大学学报 (医学版), 2023, 61(6): 65-69.
[12] 戚丹,张曦,于倩,崔琳琳,颜磊. 子宫内膜增生症及早期子宫内膜癌保留生育功能后冻胚移植妊娠结局[J]. 山东大学学报 (医学版), 2023, 61(4): 56-63.
[13] 张丽霞,田一正,吕尚格,张亚男,颜磊. GnRH-a预处理对子宫内膜异位症患者替代方案冻胚移植结局的影响[J]. 山东大学学报 (医学版), 2023, 61(10): 63-68.
[14] 李萍,何雪梅. 女性生育力评估[J]. 山东大学学报 (医学版), 2022, 60(9): 8-11.
[15] 阮祥燕,程姣姣,杜娟,谷牧青. 卵巢组织冷冻保存[J]. 山东大学学报 (医学版), 2022, 60(9): 24-30.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!